May 20, 2008 – Suven Life Sciences Ltd has announced that two product patents were granted in South Africa and China for two of their new chemical entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases and these patents are valid until 2024 and 2025 respectively.
The details can be read here.
No comments:
Post a Comment